Conflicting objectives in chemotherapy with drug resistance
β Scribed by M. I. S. Costa; J. L. Boldrini
- Publisher
- Springer
- Year
- 1997
- Tongue
- English
- Weight
- 986 KB
- Volume
- 59
- Category
- Article
- ISSN
- 1522-9602
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A logistic model of periodic chemotherapy is developed that includes drug resistance. Criteria are developed to describe the acceptable number of doses before tumor regrowth due to drug resistance occurs. The model is then compared with some clinical results, and it is shown that they qualitatively
## Background and Objectives: The extreme drug resistance (EDR) assay is an in vitro chemoresistance assay performed on tumor samples grown in culture and is claimed to predict drugs unlikely to produce response. Its clinical value in patients with epithelial ovarian cancer (EOC) has recently been
## Abstract Induction of Pβglycoproteinβrelated multiβdrugβresistance (MDR) has been shown innormal and malignant tissues to result from environmental stresses such as heat shock, exposure to carcinogens or Xβray irradiation. To identify conditions under which MDR is enhanced during antiβneoplastic
Drug resistance plays an important role in chemotherapy failure in breast cancer. We studied the expression of MDR1, MRP, LRP, DNA topoisomerases, p53 and Ki-67 in different groups of breast cancer patients in relation to chemotherapy. Tissues from 6 normal breasts and 20 primary operable, 40 locall